Journal of Leukocyte Biology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published online as doi:10.1189/jlb.1204723 on March 14, 2005

Published online before print March 14, 2005
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jlb.1204723v1
77/6/914    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gonzalez-Juarrero, M.
Right arrow Articles by Orme, I. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gonzalez-Juarrero, M.
Right arrow Articles by Orme, I. M.
(Journal of Leukocyte Biology. 2005;77:914-922.)
© 2005 by Society for Leukocyte Biology

Disruption of granulocyte macrophage-colony stimulating factor production in the lungs severely affects the ability of mice to control Mycobacterium tuberculosis infection

Mercedes Gonzalez-Juarrero*,1, Jessica M. Hattle*, Angelo Izzo*, Ana Paula Junqueira-Kipnis*, Tae S. Shim*, Bruce C. Trapnell{dagger}, Andrea M. Cooper{ddagger} and Ian M. Orme*

* Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins;
{dagger} Division of Pulmonary Biology, Children’s Hospital Research Foundation, University of Cincinnati, Ohio; and
{ddagger} Trudeau Institute, Saranac Lake, New York

1Correspondence: Mycobacteria Research Laboratories, Department of Microbiology, Immunology and Pathology, Colorado State University, 200 Lake Street, Fort Collins, CO 80523. E-mail: malba{at}lamar.colostate.edu


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Mice lacking expression of granulocyte macrophage-colony stimulating factor (GM-CSF KO) are unable to contain Mycobacterium tuberculosis (M. tuberculosis) growth and succumb to infection by 35 days following pulmonary challenge. GM-CSF KO mice do not express normal levels of the inflammatory cytokine tumor necrosis factor {alpha} (TNF-{alpha}) nor the chemokines, regulated on activation, normal T expressed and secreted (RANTES), macrophage-inflammatory protein-1ß (MIP-1ß), MIP-1{alpha}, and lymphotactin, which are required for recruitment of lymphocytes and expression of a T helper cell type 1 (TH1) response within the lungs. In contrast, transgenic mice overexpressing GM-CSF in the lungs but with a lack of GM-CSF in other organs (GM+) are able to recruit lymphocytes and to express a TH1 response with production of TNF-{alpha} and interferon-{gamma} in the lungs. However, GM+ mice succumb to infection between 60 and 90 days post-challenge, as they are unable to develop a normal granulomatous response. Although GM+ mice are able to express the chemokine RANTES, they lack the ability to express other inflammatory chemokines such as lymphotactin and MIP-1ß. We conclude that GM-CSF is essential to the recruitment of lymphocytes and expression of a TH1 response in the lung, to the generation of a normal mononuclear granuloma, and most importantly, to the containment of M. tuberculosis bacterial growth.

Key Words: GM-CSF • cytokines • chemokines • granuloma


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
The cytokine granulocyte macrophage-colony stimulating factor (GM-CSF) plays an important role in the differentiation of monocytes, alveolar macrophages, and dendritic cells [1 2 3 4 5 ]. In the lungs, the cytokine is crucially important for macrophage maturation and differentiation [5 , 6 ], surfactant homeostasis, and host defense [6 7 8 9 ]. When this cytokine is lacking, as in gene-disrupted mice, the architecture of the lungs is altered, and alveolar macrophages become foamy in appearance [1 ]. In addition, these cells have defects in phagocytosis, bacterial killing, as well as loss of Toll-like receptor expression and signaling [1 , 5 ]. Restoration of cytokine expression reverses these effects [6 , 10 ]. It is interesting that these defects in GM-CSF gene-disrupted mice seem to be expressed selectively in the lungs but not in other organs [6 ].

In mice infected in the lungs with the intracellular pathogen M. tuberculosis, macrophages play central roles [11 12 13 ]. Alveolar macrophages encounter the bacillus in the alveolar spaces, dendritic cells almost certainly carry the organism to local lymphoid tissues [14 , 15 ], and epithelioid macrophages and incoming monocytes form the basis of the tissue granuloma designed to wall-off the sites of infection and prevent further dissemination of the disease [16 , 17 ]. These cells interact throughout this process with T lymphocytes of the CD4 T helper cell type 1 (TH1), in which a cytokine pathway involving interleukin (IL)-12 and interferon-{gamma} (IFN-{gamma}) mediates the protective host response [18 19 20 ]. Disruption of this pathway leads to uncontrolled bacterial growth in the lungs, giving rise to severe granulomatous inflammation and fatal necrosis [18 ].

Given the importance of macrophage functions in controlling pulmonary tuberculosis, we examined the course of M. tuberculosis infection in the lungs of mice lacking GM-CSF (GM-CSF KO) [1 ] and in mice wherein organ-specific promoter activity leads to high expression of GM-CSF in the lungs but not other organs {surfactant protein C (SPC)-GM+/+/GM–/– mice or GM+ mice [6 , 10 ]}. The results of this study show that increased expression of GM-CSF in the lungs does not translate into increased resistance to M. tuberculosis infection and that GM+ and GM-CSF KO mice succumbed to the disease. In the latter, the disease process was rapid and characterized by severe necrotizing pneumonia, whereas the events in the GM+ mice were much slower and more complex. A prominent feature in the GM+ mice was the accumulation of mononuclear cells around blood vessels (perivascular cuffing), suggesting disruption of the normal chemokine responses needed to focus T cells and macrophages into lesions, a hypothesis further supported by our demonstration of low levels of expression of "type 1" chemokines, macrophage-inflammatory protein-1ß (MIP-1ß) and activation-induced, T cell-derived, and chemokine-related cytokine (ATAC)/lymphotactin, in the lungs of these mice. As a result of the absence of a granulomatous response in the lung tissues, bacteria formed large rafts promoting local tissue necrosis. These data suggest that in addition to promoting macrophage function in the lungs, GM-CSF also plays a role in the granulomatous response during pulmonary M. tuberculosis infection.


    MATERIALS AND METHODS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Mice
C57BL/6 mice were purchased from Jackson Laboratories (Bar Harbor, MA). These mice are referred to as wild type (WT). Mice lacking the gene expressing the GM-CSF or GM-CSF KO mice were generated by Dranoff et al. [1 ] and expressed not-detectable GM-CSF. These mice have been backcrossed extensively against C57BL/6 mice. This study also included another transgenic mice, GM+, which was generated by insertion of the human 3.7-kb SPC promoter expressing the murine GM-CSF cDNA in GM-CSF KO mice [6 , 10 ]. GM+ transgenic mice have marked elevation of GM-CSF in the lung but not in blood. Dr. B. C. Trapnell (Division of Pulmonary Biology, Children’s Hospital Medical Center, Cincinnati, OH) provided GM-CSF KO and GM+. Mice were bred at Colorado State University (Fort Collins) and maintained in a specific, pathogen-free Biosafety Level-3 (BSL-3) facility during infection with pulmonary tuberculosis. All animals had free access to water and standard mouse chow. The specific, pathogen-free nature of the mouse colonies was demonstrated by testing sentinel animals. The Colorado State University Animal Users Committee approved all experimental protocols.

Bacteria and infection
Mice were infected via the aerosol route with a low dose [~200 colony-forming units (CFU)/lung] of bacteria M. tuberculosis strain Erdman. The number of viable bacteria in the lungs and spleen was determined by plating serial dilutions of individual whole lung homogenates onto nutrient Middlebrook 7H11 agar and counting bacterial colony formation after 3 weeks incubation at 37°C. The data were expressed as the log10 value of the mean number of colonies counted (n=4 animals). Mice were monitored on a daily basis and were euthanized when they displayed symptoms associated with disease.

Histology
To study the gross histology of the lung during pulmonary tuberculosis, mice were killed at 35 days post-challenge by CO2 asphyxiation, and the lungs were infused with 10% neutral-buffered formalin prior to removing them from the thoracic cavity. The lungs were fixed in 10% neutral-buffered formalin during 72 h inside the BSL-3 laboratory.

Histological analysis of lung sections was done by hematoxylin and eosin (H&E) and acid fast staining. The accessory lobe from each mouse was also fixed in 10% neutral-buffered formalin and embedded in paraffin. Sections from these samples were made and stained for H&E or Kinyoun methods for acid fast staining.

Isolation of lung cells
Isolation of lung cells was performed by protocols already described [11 ]. Briefly, mice were killed, and the pulmonary cavity was opened. The blood circulatory system in the lungs was cleared by perfusing through the pulmonary artery with 3 ml saline containing 50 units/ml heparin (Sigma-Aldrich, St. Louis, MO). Lungs were removed aseptically and cut into small pieces in cold RPMI (Life Technologies, Grand Island, NY). The dissected tissue was then incubated in RPMI containing collagenase XI (0.7 mg/ml, Sigma-Aldrich) and type IV bovine pancreatic DNAse (30 µg/ml, Sigma-Aldrich) for 30–45 min at 37°C. The action of the enzymes was stopped by adding 10 ml completed RPMI (cRPMI) consisting of RPMI-1640 medium (Life Technologies), supplemented with 1% glutamine (Sigma-Aldrich), 0.1 mM nonessential amino acids (Life Technologies), 50 µM 2-mercaptoethanol (Sigma-Aldrich), 1% penicillin-streptomycin (Sigma-Aldrich), and 10% fetal bovine serum (FBS), and digested lungs were further disrupted by gently pushing the tissue through a nylon screen. The single-cell suspension was then washed and centrifuged at 200 g. To lyse contaminating red blood cells, the cell pellet was incubated for 5 min at room temperature with 5 ml Gey’s solution (NH4Cl and KHC03).

Tissue culture
Lung or splenocyte cell suspensions (5x106 cells/ml) from three groups of mice that were previously challenged by the aerosol route with a low dose of M. tuberculosis were cultured in the presence of M. tuberculosis culture filtrate proteins (CFP), 1 µg/ml, or media. Cells were cultured during 72 h at 37°C and 5% CO2, and the supernatants from those cultures were assayed using the inflammatory cytometric bead array (CBA) kit (BD Biosciences, San Diego, CA). Data were analyzed using CBA software. Graphs represent the average concentration for each cytokine in the supernatants from cell culture from four mice per group (n=4 for infected groups, and n=2 for naïve groups) per time-point after infection.

Analysis of cell populations in the lungs
Lung cells were suspended in deficient RPMI (Irvine Scientific, Santa Ana, CA), which was supplemented with 1% L-glutamine (Sigma-Aldrich), 1% Hepes (Sigma-Aldrich), 0.1% sodium azide (Sigma-Aldrich), and 2% FBS for flow cytometric studies.

Analysis of T cell populations was done using monoclonal antibodies (mAb) specific for mouse CD3 [145-2C11 hamster immunoglobulin G (IgG), group 1], CD4 (L3T4 clone RM4-5, rat IgG2a), CD8 (53-6.7, rat IgG2a), rat IgG2a (R35-95), rat IgG 2b (A95-1), or hamster IgG (Ha4/8), purchased from BD PharMingen (San Diego, CA) as direct conjugates to fluorescein isothyocyanate (FITC), peridinin chlorophyll-a protein (PerCP), or allophycocyanin (APC) in a purified form. Cell suspensions for each individual mouse were stained with specific mAb against murine CD3 and CD4 or CD8. Lung cells were washed in deficient RPMI (dRPMI; Irvine Scientific), which was supplemented with 1% L-glutamine, 1% Hepes, 0.1% sodium azide, and 2% FBS media, stained for 30 min at 4°C with direct conjugated antibodies, and washed twice with dRPMI. In addition, some cells were prepared for IFN-{gamma} intracellular staining by incubation at 37°C and 5% CO2 with anti-CD3 (145-2C11, 0.1 µg/ml), anti-CD28 (37.51, 1 µg/ml), and monensin (30 µM) for 4 h. After washing the cells with cell-permeabilizing solution, the presence of intracellular IFN-{gamma} was determined using a mAb against murine IFN-{gamma} (XMG1-2) conjugated to phycoerythrin (PE). Acquisition was performed on a FACSCalibur (Becton Dickinson, Mountain View, CA), and data were analyzed using CellQuest software (Becton Dickinson). Cells were gated for lymphocytes by their characteristic scatter profile, and 50,000 events in the lymphocyte gate per sample were counted.

Analysis of macrophage and dendritic cell populations was done using mAb specific for CD11c (clone HL3, hamster IgG1), CD11b (membrane-activated complex-1, clone M1/70, rat IgG2a), Gr-1 (clone RB6-8C5, rat IgG2b), CD40 (clone 3-23, rat IgG2a), major histocompatibility complex (MHC) class II antigen (clone 2G9, rat IgG2a), rat IgG2a, rat IgG2b, rat IgG1, mouse IgG2a, and hamster IgG, purchased from BD PharMingen or eBioscience (San Diego, CA) as direct conjugates to FITC, PE, PerCP, PerCP-cyanine 5.5 (PerCP-Cy5.5), or APC. Cell acquisition was performed with a dual-laser flow cytometer, FACSCalibur (Becton Dickinson). Compensation of the spectral overlap for each fluorochrome was done gating in the R1 region (see Fig. 4A ) and using CD11b antigen. The data were analyzed using CellQuest software (Becton Dickinson).



View larger version (32K):
[in this window]
[in a new window]
 
Figure 4. Comparative analysis of the macrophage and dendritic cell populations in the lung of WT, GM-CSF KO, and GM+ mice during the first 21 days of infection with M. tuberculosis. The analysis of macrophages and dendritic cell populations was done as previously reported [11 ]. (A) The expression of CD11b and CD11c markers in lung cells from naïve or infected mice was analyzed in cells gated as R1. SSC, Side-scatter; FSC, forward-scatter. (B) Number of alveolar macrophages (R2; *, P<0.004; **, P<0.001, compared with WT), dendritic cells (R3; *, P<0.008, compared with WT), or monocytes and small macrophages (R4; *, P<0.006, compared with WT) for WT (solid bars), GM-CSF KO (shaded bars), and GM+ mice (open bars). (C) Comparative expression of MHC II and CD40 antigens in each region of the CD11b/CD11c dot-plot on lung cells from WT (solid bars) and GM+ mice (open bars). The average of the mean fluorescence channel (MFC) from each group for each molecule in R2 and R3 regions of the CD11b/CD11c dot-plot was determined (*, P<0.007; **, P<0.004, compared with their respective naïve value).

 
As previously reported [11 ], cells in the R1 region were separated into five distinct cell populations according to their expression of CD11b and CD11c (see Fig. 4A ). These populations were comprised of CD11bneg/CD11c+/high cells (R2), CD11b+/CD11c+/high (R3), CD11b+/mid/CD11c+/mid (R4), CD11b+/mid/CD11cneg (R5), and CD11b+high/CD11cneg (R6).

RNAse protection assay (RPA)
A multiprobe RPA system mCK-5c from BD PharMingen was used to determine mRNA levels from genes of interest in the lungs of WT, GM-CSF KO, or GM+ mice after 0 or 21 days post-challenge with M. tuberculosis. The relative gene expression was determined and compared with the expression of housekeeping gene glyceraldehyde 3-phosphate dehydrogenase (GAPDH). The relative gene expression from each chemokine with housekeeping gene was analyzed using a densitometer, ImageQuant 1999 software (Molecular Dynamics, Sunnyvale, CA).

Statistical analysis
Student’s t-test was used for comparisons of means, and values of P < 0.05 were considered statistically significant.


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Susceptibility of mouse strains to pulmonary infection with M. tuberculosis
To determine whether GM-CSF levels within the lung alter the susceptibility of mice to aerosol infection with M. tuberculosis, WT, GM-CSF KO, and GM+ mice were exposed to a low-dose aerosol infection, and the course of bacterial growth was followed for up to 90 days (Fig. 1B ). Bacterial growth was equivalent over the first 21 days of the infection, regardless of the level of GM-CSF in the lungs, but thereafter, the GM-CSF KO mice were unable to contain the bacterial growth and succumbed to the infection by day 35 (Fig. 1A) . In contrast the GM+ mice were able to limit bacterial growth to a limited extent; however, bacteria accumulated slowly, and animals began to die after 60–70 days (Fig. 1A) . As anticipated, the WT mice were able to limit bacterial growth and sustained control of bacterial accumulation throughout the period of the experiment.



View larger version (15K):
[in this window]
[in a new window]
 
Figure 1. Bacterial load in the lungs and spleen of (A) WT (o), GM-CSF KO ({square}), and GM+ ({Delta}) mice after infection with M. tuberculosis. Mice were infected with ~102 M. tuberculosis Erdman strain by the aerosol route. Data represent the mean ± SEM from four mice at each individual time-point and are representative of three to five independent experiments. *, P < 0.03; **, P < 0.004.

 
In contrast to the data from the lung, the bacterial load in the spleen was similar among all experimental groups, and no decreased ability to control bacterial growth was seen in the gene-altered mice until day 90 when GM+ had a significant increase in bacteria load compared with WT (Fig. 1B) . It would appear therefore that the adverse events in the lungs did not result in increased dissemination from the lung to the spleen until late in infection and that this organ was able to contain the bacterial growth.

Differences observed in lung pathology in the three strains
Lymphocytic peribronchiolar and perivascular aggregation followed by formation of granuloma structures in the lungs are the hallmark of containment of M. tuberculosis bacterial growth in WT mice [16 , 21 ]. As shown in Figure 2 , although WT mice exhibit this normal progression of events, the gene-altered mice differ significantly from the norm.



View larger version (54K):
[in this window]
[in a new window]
 
Figure 2. Lung pathology in WT, GM-CSF KO, and GM+ mice after aerosol infection with M. tuberculosis. (A) Gross appearance of WT, GM-CSF KO, and GM+ mice after 35 days of infection with M. tuberculosis. (B) H&E staining of lung sections obtained from WT, GM-CSF KO, and GM+ mice. Arrows indicate lymphocytic granuloma formation (top), an extensive lesion with severe necrosis (middle), and a perivascular lymphocytic aggregation or cuff (bottom), respectively. (C) Acid fast staining of lung sections, with arrows indicating bacteria. (B and C) Total original magnification, 5x and 50x, respectively.

 
One of the most obvious differences between the WT and GM+ mice was noted at the gross level when it is apparent that the GM+ lungs fail to exhibit a granulomatous appearance. In contrast, the GM-CSF KO mice exhibit a pronounced ability to generate lesions, which apparently occlude the majority of healthy tissue. The WT mice exhibit the expected development of grossly detectable granulomas (Fig. 2A)

When tissues were sectioned and analyzed for immunopathologic consequences of infection, the differences observed at the gross level were recapitulated at the microscopic level (Fig. 2B) . Specifically, lesions in WT mice showed the characteristic mononuclear granulomatous formation, and this level of organization was absent in the lungs of GM-CSF KO mice in which much of the lung tissues contained large areas of severe necrosis and tissue damage. As suggested by the gross examination of the tissue, the lungs of GM+ mice showed little evidence of granuloma formation, and instead, the primary facet of the lung sections from these mice was prominent perivascular and peribronchiolar cuffs of mononuclear cells.

The location of bacteria within the lesions was also altered between the strains of mice. As expected, the WT mice had low numbers of bacteria that were located within the granulomata; in contrast, there were prominent clumps of bacteria in the lungs of GM-CSF KO mice, and bacteria were scattered widely in the GM+ mice (Fig. 2C) .

Cellular influxes in the lungs
An effective acquired immune response against pulmonary M. tuberculosis infection is associated with recruitment of lymphocytes and the presence of IFN-{gamma}-producing cells [18 , 20 ] in the lungs. To determine whether the reduced resistance of the gene-altered mice was associated with the inability to accumulate lymphocytes in the lung upon infection, the number of potentially protective lymphocytes within the lungs of infected animals was determined. As shown in Figure 3A , mice unable to produce GM-CSF did not increase the numbers of lymphocytes in the lungs; however, mice overexpressing GM-CSF in the lungs, as in GM+ mice, had similar numbers of lymphocytes than WT animals, but as shown above, these were not reaching the sites of infection in the lung tissues. Similarly, after 21 days of infection, there was a significant accumulation of IFN-{gamma}-producing CD4+ and CD8+ lymphocytes in the lungs of infected WT mice and GM+ mice. In sharp contrast, mice unable to produce GM-CSF were unable to accumulate this type of cell into the lungs (Fig. 3B) .



View larger version (27K):
[in this window]
[in a new window]
 
Figure 3. T cell recruitment to the lungs of WT, GM-CSF KO, and GM+ mice during the first 21 days of with M. tuberculosis. (Left) Data are expressed as the means and SEM of total numbers of cells for each T cell population from four mice per group compared with cells harvested from age-matched, uninfected, naïve controls. (Right) Representative dot-plots of samples from each group obtained at 21 days post-challenge. (A) CD3+/CD4+ (solid bars) and CD3+/CD8+ (open bars).*, P < 0.04; **, P < 0.02, compared with WT. (B) Total number of CD4+/IFN-{gamma}+ (solid bars) and CD8+/IFN-{gamma}+ (open bars). *, P < 0.04; **, P < 0.03, compared with WT. Data are representative of three independent experiments.

 
The central element of the granulomatous response to M. tuberculosis infection is the influx of macrophages into the lungs. We previously reported that during infection, monocytes, macrophages, and dendritic cells accumulate in lungs and undergo phenotypic changes associated with infection [11 ]. As GM-CSF is a known mediator of maturation and functional development for macrophages and dendritic cells [2 , 22 ], we wanted to determine whether macrophage and dendritic cell accumulation and maturation were affected when levels of GM-CSF were altered in the lung. As shown in Figure 4 , there were clear differences in the expression of CD11b and CD11c molecules on large cells accumulating within the lungs, depending on whether GM-CSF was absent or overexpressed. It appeared that CD11b-positive cells were unable to express CD11c in the absence of GM-CSF, whereas there were novel populations of CD11b and CD11c-positive cells in GM+ mice. It was apparent that the altered cell-surface phenotype was reflected in altered numbers of specific cell types. Specifically, the number of alveolar macrophages (R2), dendritic cells (R3), and monocytes and small macrophages (R4) increased in the WT and GM+ mice but was lower in GM-CSF KO mice (Fig. 4B) .

To address the activation state of the macrophages and dendritic cells within the infected lungs, the levels of expression of activation markers CD40 and MHC II in each cell population were determined in the WT and GM+. (GM-CSF KO mice were not analyzed, as there were not CD11c-positive cells.) Figure 4C shows that the expression of these antigens did not differ within the alveolar macrophage population; however, the expression of CD40 antigens but not MHC II antigens was higher on the dendritic cells from infected lung. (The difference in MFC for CD40 expression between WT and GM+ after infection was not statistically significant.)

The profile of inflammatory cytokines produced after infection differed among the mouse strains
It is apparent from the above data that the level of GM-CSF within the lung has an important effect on granuloma formation and accumulation of lymphocytes within the lung. Key mediators of granuloma formation and effector T cell accumulation are the inflammatory cytokines that are expressed in the lung upon infection.

To determine whether the level of GM-CSF alters levels of inflammatory cytokines, we analyzed the production of these cytokines by lung cells from infected mice in response to CFP from M. tuberculosis. In the absence of GM-CSF, lung cells were less able to produce tumor necrosis factor-{alpha} (TNF-{alpha}) and IFN-{gamma} in response to antigen when compared with WT or GM+ mice. In contrast, the ability of lung cells from GM-CSF KO mice to produce IL-6 in response to antigen was far greater than with WT or GM+ lung cells (Fig. 5A ).



View larger version (21K):
[in this window]
[in a new window]
 
Figure 5. Cytokine secretion by lung cell cultures after stimulation with CFP of M. tuberculosis. Lung cells were obtained from WT (solid bars), GM-CSF KO (shaded bars), and GM+ (open bars) mice after 21 days of infection. Lung cells were cultured in the presence of CFP from M. tuberculosis or with media alone. CBA was used to analyze the presence of TNF-{alpha}, IL-10, IL-6, and IFN-{gamma} in the supernatant of lung cell cultures. The data are represented as the individual mean ± SEM (n=4) in pg/ml (*, P<0.0006; **, P<0.01; ***, P<0.004, compared with WT value). (B) Comparative levels of expression of IFN-{gamma} lung (solid bars) or splenocyte (open bars) cell cultures with CFP from M. tuberculosis or with media alone (*, P<0.043; **, P<0.031; ***, P<0.036, compared with their respective media value).

 
To determine whether the GM-CSF KO mice were simply unable to generate an IFN-{gamma}-producing antigen-specific response, the ability of lung cells and splenocytes to produce IFN-{gamma} in response to antigen was assessed. As expected, cells from the lungs of infected WT mice made more IFN-{gamma} than cells from the spleen. In contrast, in the absence of GM-CSF, as there was no antigen-specific response in the lung, there was a clear response in the spleen (P<0.043). In the presence of excess GM-CSF in the lung, there was a decreased but significant antigen-specific response in the lung (P<0.031) and a significant and increased response in the spleen (P<0.036; Fig. 5B ).

Changes in resistance and lung histology correlate with decreased production of inflammatory chemokines including ATAC/lymphotactin and MIP-ß
In addition to a role for inflammatory cytokines, the chemokines are crucially important in the development of granulomas and the accumulation of cells within tissues. The failure of GM+ mice to adequately focus lymphocytes and macrophages into the lung tissues suggested a potential defect in the appropriate production of chemokine gradients. To determine whether chemokine expression was indeed defective in the presence of excess GM-CSF, we determined the mRNA levels for chemokines within the lungs of infected mice. Although the pattern of chemokine expression was different for each experimental group, it was apparent that the absence of GM-CSF resulted in defective expression of mRNA for the T cell-recruiting chemokines RANTES, ATAC/lymphotactin, and MIP-1ß, with increased mRNA expression of MIP-{alpha} when compared with the expression of mRNA in the WT. In contrast, the overexpression of GM-CSF resulted in similar expression of mRNA for RANTES as the WT but reduced expression of MIP-ß and ATAC/lymphotactin (Fig. 6 ).



View larger version (27K):
[in this window]
[in a new window]
 
Figure 6. Chemokines profile in lungs from WT, GM-CSF KO, and GM+ mice. The results represent the mean ± SEM ratios of the gene of interest (chemokines) versus the L32 and GAPDH housekeeping gene at 21 (n=3; solid bars) days post-chellenge with M. tuberculosis or naïve (n=2; open bars) from WT, GM-CSF KO, and GM+ mice. The data are representative of two experiments. RNA from the lungs of each strain of mice was extracted at 0 (n=2) or 21 (n=3) days post-challenge with M. tuberculosis. (Right) Numbers at top represent the lane numbers in the gel. Lane 14 contains unprotected probe (marker), and lanes 1–5 (GM+), 6–10 (GM-CSF KO), and 11–16 (WT) correspond to protected probes from each individual mouse. IP-10, IFN-inducible protein 10; Rantes, regulated on activation, normal T expressed and secreted; TCA-3, T cell activation gene 3; MCP-1, monocyte chemoattractant protein 1.

 

    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
The results of this study show that mice lacking GM-CSF are incapable of controlling an aerosol-delivered infection with M. tuberculosis and die rapidly from severe necrosis in the lungs driven by the progressively increasing organ bacterial load. It was expected, therefore, that in GM+ mice capable of overproducing this cytokine, a higher level of protection would be seen, but this was not the case. Instead, the bacterial load slowly increased over time, and histological analysis of the lungs revealed a mononuclear cell infiltrate, which failed to progress beyond the margins of blood vessels, and resulted in the total failure of normal granuloma formation. These data together indicate that there is a fine homeostatic balance controlling GM-CSF production in the lungs and that lack of production or overproduction in both cases eventually has fatal outcomes when the animal is faced with a virulent pathogen such as M. tuberculosis.

The failure of GM+ mice to focus T cells and macrophages into sites of infection in the lungs suggests a defect in cytokine and chemokine control of this event. This hypothesis is supported by our observation that the GM+ mice had normal levels of proinflammatory (TNF-{alpha}) and chemokine RANTES but decreased levels of expression of MIP-1ß and ATAC/lymphotactin.

The dependence of antibacterial activity and granuloma formation on TNF-{alpha} and the reduced levels of this cytokine in the GM-CSF KO mice are suggestive of why these mice are highly susceptible to M. tuberculosis infection. Defective expression of TNF-{alpha} and innate responses to other microbial infections in GM-CSF KO were reported previously [5 ]. Similarly, the absence of RANTES, MIP-ß, and ATAC/lymphotactin in the GM-CSF KO mice may explain their lack of ability to focus what is apparently a normal, splenic, antigen-specific response to the lung.

The lack of granulomatous response in the GM+ mice appeared to be the reason for the lack of containment of bacterial growth during the chronic stage of infection. GM+ mice have similar activation capacity of their dendritic and alveolar macrophage cell populations as the WT and were able to recruit lymphocytes into the lungs. It is interesting that the cytokine TNF-{alpha}, which is essential for leukocyte recruitment into the lung, had similar levels of expression in GM+ and WT. However, leukocyte recruitment is also dependent on the expression of inflammatory chemokines type 1, such as RANTES, MIP-1{alpha}, and MIP-1ß, and the expression of these chemokines differed between both groups of mice. These chemokines are usually produced de novo in response to infection and are known to be important in recruiting effector cells to sites of infection [23 ], primarily via the CC chemokine receptor 5, found on macrophages, dendritic cells, and activated CD4 T cells [24 ]. ATAC/lymphotactin is more selectively secreted by natural killer (NK) cells and CD8 cells [25 ], both of which are known to respond to M. tuberculosis infection. We hypothesize therefore that overproduction of GM-CSF in the lungs depresses the production of the type 1 chemokines MIP-1ß and ATAC/lymphotactin but not RANTES, possibly by a physiological feedback inhibition mechanism. It is likely that cell extravasation occurs through the blood vessel mediated by the presence of RANTES, but once inside the lungs, leukocytes are prevented from further movement out into the lung tissues as a result of the lack of ATAC/lymphotactin and MIP-ß type 1 chemokines. Conversely, outside the lungs, events appear to be proceeding normally, and dendritic cells carry bacteria to lymphoid tissues or to the spleen, and the TH1 response emerges as expected.

These observations have similarities to other models. The progressive disease in the lungs of GM-CSF KO mice is similar to that in IFN-{gamma} KO mice and was associated in both cases with severe necrosis and rapid death in the absence of any intact granuloma formation [18 ]. In the case of the GM+ mice, the perivascular cuffing and lack of further cellular influx are similar to that in M. tuberculosis-infected mice lacking the ß2-microglobulin molecule [26 ]. This may suggest that lack of production of type 1 chemokines (specifically, ATAC/lymphotactin) by MHC I-restricted CD8 or NK cells in the lungs may underlie this event, and this should be investigated further.

These findings indicate that the cytokine GM-CSF plays a selective and specific role in the lungs, controlling the maturation and differentiation of macrophage populations as well as affecting the homeostatic, local production of chemokine molecules that influence the influx of macrophages and activated T cells from the blood across the pulmonary vasculature. When GM-CSF is overexpressed, this homeostasis is disrupted, depressing specific type 1 chemokine production and preventing proper granuloma formation in the lung tissues.


    ACKNOWLEDGEMENTS
 
This work was supported by National Institutes of Health Grants AI-40488 and AI-44072. The authors thank Dr. R Basaraba (Colorado State University) for his collaboration with the histology picture and Dr. Wilusz’ laboratory (Colorado State University) for help with the RNase protection assay.

Received December 13, 2004; revised January 25, 2005; accepted February 3, 2005.


    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Dranoff, G., Crawford, A. D., Sadelain, M., Ream, B., Rashid, A., Bronson, R. T., Dickersin, R., Bachurski, C. J., Mark, E. L., Whitsett, J. A., Mulligan, R. C. (1994) Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis Science 264,713-716[Abstract/Free Full Text]
  2. Inaba, K., Inaba, M., Romani, N., Aya, H., Deguchi, M., Ikehara, S., Maramatsu, S., Steinman, R. M. (1992) Generation of large numbers of dendritic cells from bone marrow cultures supplemented with granulocyte/macrophage colony-stimulatory factor J. Exp. Med. 176,1693-1702[Abstract/Free Full Text]
  3. Mach, N., Gillessen, S., Wilson, S. B., Sheehan, C., Mihm, M., Dranoff, G. (2000) Differences in dendritic cells stimulated in vivo by tumors engineered to secrete granulocyte-macrophage colony-stimulating factor or Flt3-ligand Cancer Res. 60,3239-3246[Abstract/Free Full Text]
  4. Randolph, G. J., Kayo, I., Davide, R. F., Ralph, S. M., William, M. A. (1999) Differentiation of phagocytic monocytes into lymph node dendritic cells in vivo Immunity 11,753-761[CrossRef][Medline]
  5. Shitaba, Y., Berclaz, P-Y., Chroneos, Z. C., Yoshida, M., Whitsett, J. A., Trapnell, B. (2001) GM-CSF regulates alveolar macrophage differentiation and innate immunity in the lung through PU.1 Immunity 15,557-567[CrossRef][Medline]
  6. Trapnell, B. C., Whitsett, J. A. (2002) GM-CSF regulates pulmonary surfactant homeostasis and alvoelar macrophage-mediated innate host defense Annu. Rev. Physiol. 64,775-802[CrossRef][Medline]
  7. Ikegami, M., Ueda, T., Hull, W., Whitsett, J. A., Mulligan, R. C., Dranoff, G., Jobe, A. H. (1996) Surfactant metabolism in transgenic mice after granulocyte macrophage-colony stimulating factor ablation Am. J. Physiol. 270,L650-L658
  8. Reed, J. A., Ikegami, M., Cianciolo, E. R., Lu, W., Cho, P. S., Huli, W., Jobe, A. H., Whitsett, J. A. (1999) Aerosolized GM-CSF ameliorates pulmonary alveolar proteinosis in GM-CSF-deficient mice Am. J. Pysiol. 276,L556-L563
  9. Yoshida, M., Ikegami, M., Reed, J. A., Chroneos, Z. C., Whitsett, J. A. (2001) GM-CSF regulates protein and lipid catabolism by alveolar macrophages Am. J. Physiol. Lung Cell. Mol. Physiol. 280,L379-L386[Abstract/Free Full Text]
  10. Huffman, J., Dranoff, H. W., Dranoff, G., Mulligan, R., Whisett, J. (1996) Pulmonary epithelial cell expression of GM-CSF corrects the alveolar proteinosis in GM-CSF-deficient mice J. Clin. Invest. 97,589-590[Medline]
  11. Gonzalez-Juarrero, M., Shim, T. S., Kipnis, A., Junqueira-Kipnis, A. P., Orme, I. M. (2003) Dynamics of macrophage cell populations during murine pulmonary tuberculosis J. Immunol. 171,3128-3135[Abstract/Free Full Text]
  12. Mwandumba, H. C., Russell, D. G., Nyirenda, M. H., Anderson, J., White, S. A., Molyneux, M. E., Squire, S. B. (2004) Mycobacterium tuberculosis resides in nonacidified vacuoles in endocytically competent macrophages from patients with tuberculosis and HIV infection J. Immunol. 172,4592-4598[Abstract/Free Full Text]
  13. Russell, D. G. (1995) Of microbes and macrophages: entry, survival and persistence Curr. Opin. Immunol. 7,479-484[CrossRef][Medline]
  14. Bodnar, K. A., Serbina, N. V., Flynn, J. L. (2001) Fate of Mycobacterium tuberculosis within murine dendritic cells Infect. Immun. 69,800-809[Abstract/Free Full Text]
  15. Simeone, M., Pawar, S., Fuller, C. L., Reinhart, T. A., Flynn, J. L., Kirschner, D. E. (2004) Dendritic cell trafficking and antigen presentation in the human immune response to Mycobacterium tuberculosis J. Immunol. 173,494-506[Abstract/Free Full Text]
  16. Gonzalez-Juarrero, M., Turner, O. C., Turner, J., Marietta, P., Brooks, J. V., Orme, I. M. (2001) Temporal and spatial arrangement of lymphocytes within lung granulomas induced by aerosol infection with Mycobacterium tuberculosis Infect. Immun. 69,1722-1728[Abstract/Free Full Text]
  17. Turner, O. C., Basaraba, R. J., Frank, A. A., Orme, I. M. (2003) Granuloma formation in mouse and guinea pig models of experimental tuberculosis Boros, D. L. eds. Granuloma Infections and Inflammations: Cellular and Molecular Mechanism ,65-83 ASM Washington, DC.
  18. Cooper, A. M., Dalton, D. K., Stewart, T. A., Griffin, J. P., Russell, D. G., Orme, I. M. (1993) Disseminated tuberculosis in interferon {gamma} gene-disrupted mice J. Exp. Med. 178,2243-2247[Abstract/Free Full Text]
  19. Cooper, A. M., Kipnis, A., Turner, J., Magram, J., Ferrante, J., Orme, I. M. (2002) Mice lacking bioactive IL-12 can generate protective, antigen-speciifc cellular responses to mycobacterial infection only if the IL-12 p40 subunit is present J. Immunol. 168,1322-1327[Abstract/Free Full Text]
  20. Flynn, J. L., Chan, J., Triebold, K. J., Dalton, D. K., Stewart, T. A., Bloom, B. R. (1993) An essential role for interferon {gamma} in resistance to Mycobacterium tuberculosis infection J. Exp. Med. 178,2249-2254[Abstract/Free Full Text]
  21. Saunders, B. M., Frank, A. A., Orme, I. M. (1999) Granuloma formation is required to contain bacilli growth and delay mortality in mice chronically infected with Mycobacterium tuberculosis Immunology 98,324-328[CrossRef][Medline]
  22. Inaba, K., Inaba, M., Deguchi, M., Hagi, K., Yasumizu, R., Ikehara, S., Muramatsu, S., Steinman, R. M. (1993) Granulocytes, macrophages, and dendritic cells arise from a common major histocompatibility complex class II-negative progenitor in mouse bone marrow Proc. Natl. Acad. Sci. USA 90,3038-3042[Abstract/Free Full Text]
  23. Moser, B., Loetscher, P. (2001) Lymphocyte traffic control by chemokines Nat. Immunol. 2,123-128[CrossRef][Medline]
  24. Baggiolini, M., Loetscher, P. (2000) Chemokines in inflammation and immunity Immunol. Today 21,418-420[CrossRef][Medline]
  25. Dorner, B. G., Scheffold, A., Rolph, M. S., Huser, M. B., Kaufmann, S. H. E., Radbruch, A., Flesch, I. E. A., Kroczek, R. A. (2002) MIP-1{alpha}, MIP-1ß, RANTES, and ATAC/lymphotactin function together with IFN-{gamma} as type 1 cytokines Proc. Natl. Acad. Sci. USA 99,6181-6186[Abstract/Free Full Text]
  26. D’Souza, C. D., Cooper, A. M., Frank, A. A., Ehlers, S., Turner, J., Bendelac, A., Orme, I. M. (2000) A novel nonclassic ß2-microglobulin-restricted mechansim influencing early lymphocyte accumulation and subsequent resistance to tuberculosis in the lung Am. J. Respir. Cell Mol. Biol. 23,188-193[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
J. Immunol.Home page
D. M. Higgins, J. Sanchez-Campillo, A. G. Rosas-Taraco, J. R. Higgins, E. J. Lee, I. M. Orme, and M. Gonzalez-Juarrero
Relative Levels of M-CSF and GM-CSF Influence the Specific Generation of Macrophage Populations during Infection with Mycobacterium tuberculosis
J. Immunol., April 1, 2008; 180(7): 4892 - 4900.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. A. Ryan, T. M. Wozniak, E. Shklovskaya, M. A. O'Donnell, B. Fazekas de St. Groth, W. J. Britton, and J. A. Triccas
Improved Protection against Disseminated Tuberculosis by Mycobacterium bovis Bacillus Calmette-Guerin Secreting Murine GM-CSF Is Associated with Expansion and Activation of APCs
J. Immunol., December 15, 2007; 179(12): 8418 - 8424.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
D. Ordway, D. M. Higgins, J. Sanchez-Campillo, J. S. Spencer, M. Henao-Tamayo, M. Harton, I. M. Orme, and M. Gonzalez Juarrero
XCL1 (lymphotactin) chemokine produced by activated CD8 T cells during the chronic stage of infection with Mycobacterium tuberculosis negatively affects production of IFN-{gamma} by CD4 T cells and participates in granuloma stability
J. Leukoc. Biol., November 1, 2007; 82(5): 1221 - 1229.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
G.-H. Chen, M. A. Olszewski, R. A. McDonald, J. C. Wells, R. Paine III, G. B. Huffnagle, and G. B. Toews
Role of Granulocyte Macrophage Colony-Stimulating Factor in Host Defense Against Pulmonary Cryptococcus neoformans Infection during Murine Allergic Bronchopulmonary Mycosis
Am. J. Pathol., March 1, 2007; 170(3): 1028 - 1040.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. Carey, M. K. Staudt, D. Bonaminio, J. C. M. van der Loo, and B. C. Trapnell
PU.1 Redirects Adenovirus to Lysosomes in Alveolar Macrophages, Uncoupling Internalization from Infection
J. Immunol., February 15, 2007; 178(4): 2440 - 2447.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
K. Uchida, D. C. Beck, T. Yamamoto, P.-Y. Berclaz, S. Abe, M. K. Staudt, B. C. Carey, M.-D. Filippi, S. E. Wert, L. A. Denson, et al.
GM-CSF Autoantibodies and Neutrophil Dysfunction in Pulmonary Alveolar Proteinosis
N. Engl. J. Med., February 8, 2007; 356(6): 567 - 579.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
P.-Y. Berclaz, B. Carey, M.-D. Fillipi, K. Wernke-Dollries, N. Geraci, S. Cush, T. Richardson, J. Kitzmiller, M. O'Connor, C. Hermoyian, et al.
GM-CSF Regulates a PU.1-Dependent Transcriptional Program Determining the Pulmonary Response to LPS
Am. J. Respir. Cell Mol. Biol., January 1, 2007; 36(1): 114 - 121.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
T. C. Thacker, M. V. Palmer, and W. R. Waters
Correlation of Cytokine Gene Expression with Pathology in White-Tailed Deer (Odocoileus virginianus) Infected with Mycobacterium bovis
Clin. Vaccine Immunol., June 1, 2006; 13(6): 640 - 647.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Ordway, M. Harton, M. Henao-Tamayo, R. Montoya, I. M. Orme, and M. Gonzalez-Juarrero
Enhanced Macrophage Activity in Granulomatous Lesions of Immune Mice Challenged with Mycobacterium tuberculosis.
J. Immunol., April 15, 2006; 176(8): 4931 - 4939.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
J. A. Tree, M. J. Elmore, S. Javed, A. Williams, and P. D. Marsh
Development of a Guinea Pig Immune Response-Related Microarray and Its Use To Define the Host Response following Mycobacterium bovis BCG Vaccination
Infect. Immun., February 1, 2006; 74(2): 1436 - 1441.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jlb.1204723v1
77/6/914    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gonzalez-Juarrero, M.
Right arrow Articles by Orme, I. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gonzalez-Juarrero, M.
Right arrow Articles by Orme, I. M.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS